☆ 4.6 Letter

Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry

BRITISH JOURNAL OF DERMATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。
Letter Dermatology

Dose spacing and reduction strategies in biotherapies for stable, clear or almost clear psoriasis: A survey of practices in France

H. Aubert et al.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2022)

添加到收藏夹
Review Pharmacology & Pharmacy

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

C. A. J. Michielsens et al.

Summary: Biologic tapering appears to be effective and safe in psoriasis patients with stable low disease activity or clinical remission. More research is needed to address the current gaps in knowledge, particularly in terms of tapering criteria and strategies, long-term safety, predictors for successful tapering, cost-effectiveness, and evaluation of newer generation biologics.

DRUGS (2021)

添加到收藏夹
Article Dermatology

Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

Selma Atalay et al.

Summary: The study found that a tightly controlled dose reduction strategy for adalimumab, etanercept, and ustekinumab in patients with psoriasis can safely decrease drug dosages and maintain the use of lower doses.

ACTA DERMATO-VENEREOLOGICA (2021)

添加到收藏夹
Article Dermatology

Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis A Randomized Clinical Trial

Selma Atalay et al.

JAMA DERMATOLOGY (2020)

添加到收藏夹
研讨会 海报 问题 讨论圈 基金 期刊 论文 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.